BEAT-Breast: Trial of DE-iPTV in Patients With Primary Breast Cancer With Brain Metastases Who Are Not Suitable for Stereotactic Radiotherapy.

The aim of this study is to demonstrate if it is possible to delivering a novel and modern radiotherapy approach (Dose Escalated internal PTV (DE-iPTV)) and to collect health related quality of life in patients whose breast cancer has spread to the brain (brain metastases) at 8 weeks post enrolling into the study. The main questions that have been set out to to answer are: * Is it possible to deliver the novel radiotherapy approach, DE-iPTV? * Is it possible to measure health -related quality of life? * What impact does the novel radiotherapy approach have on: patient's quality of life, cont

Trial Details

NCT ID
NCT06611306
Phase
NA
Sponsor
Imperial College London
Status
RECRUITING
Cancer Type
Breast Cancer
Interventions
  • DE-iPTV
Locations (sample)
  • London, London, United Kingdom|51.50853,-0.12574
  • Oxford, United Kingdom|51.75222,-1.25596

Key Eligibility Criteria

  • Written (signed and dated) informed consent and be capable of co-operating with treatment and follow-up
  • Adult (aged 16+) patients, resident in the United Kingdom.
  • Histologically confirmed primary breast cancer with brain metastases on MRI imaging
  • The treating oncologist considers whole-brain radiotherapy to be the most suitable treatment outside of the trial.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Breast Cancer Trials on Trialify →